Beta%252525252525252525252525252525252525252525252525252520blockers

# Beta Blockers ## Overview Beta-adrenergic blocking agents (beta blockers) are a class of drugs that primarily work by blocking the effects of epinephrine and norepinephrine on beta-adrenergic receptors. This leads to a decrease in heart rate, myocardial contractility, and blood pressure. They can be cardioselective (primarily blocking beta-1 receptors, e.g., metoprolol, atenolol) or non-selective (blocking both beta-1 and beta-2 receptors, e.g., propranolol, nadolol). Some also possess alpha-blocking activity (e.g., labetalol, carvedilol). ## Primary Indications * Hypertension * Angina Pectoris * Myocardial Infarction (post-MI management) * Arrhythmias (e.g., supraventricular tachycardia, atrial fibrillation rate control) * Heart Failure (specific agents like carvedilol, metoprolol succinate, bisoprolol) * Migraine Prophylaxis (non-selective agents) * Essential Tremor (non-selective agents) * Glaucoma (topical agents like timolol) * Hyperthyroidism symptoms (rate control) * Pheochromocytoma (adjunct therapy) ## Adult Dosing Dosing is highly variable depending on the specific beta blocker, indication, and patient response. Titration is often required. * **Hypertension:** * Metoprolol tartrate: 50-100 mg twice daily, usual range 100-400 mg/day. * Metoprolol succinate: 25-50 mg once daily, usual range 50-200 mg/day. * Atenolol: 25-50 mg once daily, usual range 50-100 mg/day. * Propranolol: 40 mg twice daily, usual range 120-240 mg/day (divided doses). * Carvedilol: 3.125 mg twice daily, usual range 12.5-25 mg twice daily. * Labetalol: 100-200 mg twice daily, usual range 200-1200 mg/day (divided doses). * **Heart Failure:** * Carvedilol: Initiate at 3.125 mg twice daily, titrate gradually over weeks to target dose of 25 mg twice daily (for patients < 85 kg) or 50 mg twice daily (for patients >= 85 kg). * Metoprolol succinate: Initiate at 12.5-25 mg once daily, titrate gradually over weeks to target dose of 200 mg once daily. * Bisoprolol: Initiate at 2.5 mg once daily, titrate gradually over weeks to target dose of 10 mg once daily. * **Post-MI:** Typically started within 24 hours of stable hemodynamics. * Metoprolol tartrate: 50 mg every 6 hours for 48 hours, then 100 mg twice daily. * **Arrhythmias (rate control):** * Metoprolol tartrate: 25-50 mg every 6-12 hours. * Esmolol: Loading dose 500 mcg/kg over 1 minute, then infusion 50-300 mcg/kg/min. ## Pediatric Dosing Pediatric dosing is complex and often based on weight and clinical condition. Dosing recommendations can vary significantly. Consult specific pediatric guidelines or drug monographs. * **Hypertension:** * Propranolol: Typically 0.5-2 mg/kg/day divided into 2-3 doses. Max dose generally 4-6 mg/kg/day. * Atenolol: Typically 0.5-1 mg/kg/day once daily. Max dose generally 2 mg/kg/day. * Metoprolol: Typically 0.5-2 mg/kg/day divided into 2-3 doses. Max dose generally 3 mg/kg/day. ## Dose Adjustments * **Renal Impairment:** Metoprolol, atenolol, nadolol require dose adjustment. Propranolol and carvedilol generally do not require significant adjustment unless severe. * **Hepatic Impairment:** Metoprolol, propranolol, carvedilol may require dose reduction. ## Contraindications * Hypersensitivity to beta blockers. * Second- or third-degree atrioventricular (AV) block without a pacemaker. * Sick sinus syndrome. * Cardiogenic shock. * Decompensated heart failure requiring IV inotropic therapy. * Severe bradycardia. * Severe peripheral arterial disease (caution with non-selective agents). * Bronchospastic disease (e.g., asthma, COPD) with non-selective beta blockers (relative contraindication, cardioselective preferred). ## Adverse Effects * **Cardiovascular:** Bradycardia, hypotension, dizziness, fatigue, cold extremities, AV block, heart failure exacerbation. * **Respiratory:** Bronchospasm (especially with non-selective agents). * **CNS:** Fatigue, depression, vivid dreams, insomnia. * **Metabolic:** Masking of hypoglycemia symptoms (except sweating), hyperglycemia (especially non-selective). * **Gastrointestinal:** Nausea, diarrhea, constipation. * **Other:** Impotence, rash. ## Key Drug Interactions * **Calcium Channel Blockers (e.g., verapamil, diltiazem):** Additive negative chronotropic and inotropic effects, increased risk of bradycardia, AV block, and heart failure. * **Antiarrhythmics (e.g., amiodarone, digoxin):** Additive bradycardia and AV conduction depression. * **Insulin/Oral Hypoglycemics:** Beta blockers can mask hypoglycemia symptoms (tachycardia, tremor). * **CYP450 Inhibitors/Inducers:** Can affect metabolism of some beta blockers (e.g., propranolol, metoprolol). * **Epinephrine:** Non-selective beta blockers can potentiate the pressor response of epinephrine by blocking beta-mediated vasodilation. * **NSAIDs:** May reduce antihypertensive effects. ## Monitoring * **Blood Pressure:** Regularly, especially during titration. * **Heart Rate:** Regularly, assess for bradycardia. * **ECG:** Assess for AV block, especially with initiation or dose increases. * **Signs/Symptoms of Heart Failure:** Monitor for dyspnea, edema, weight gain. * **Blood Glucose:** In diabetic patients, especially if experiencing hypoglycemia. * **Renal and Hepatic Function:** As clinically indicated. ## Clinical Pearls * Start low and go slow, particularly in elderly patients and those with heart failure. * Abrupt discontinuation can lead to rebound hypertension, angina, or myocardial infarction. Taper gradually over 1-2 weeks. * Cardioselective agents (beta-1 selective) are generally preferred in patients with reactive airway disease, but caution is still advised. * Labetalol and carvedilol have alpha-blocking properties which contribute to vasodilation and are beneficial in heart failure and hypertension. * Non-selective beta blockers are indicated for migraine prophylaxis and essential tremor. * Metoprolol tartrate is for immediate release; metoprolol succinate is for extended release. They are not interchangeable. *** *Disclaimer: This information is intended for educational purposes and does not substitute for professional medical advice. Always verify current prescribing information with the official drug product labeling or a reliable drug information resource before making any clinical decisions.*